Chimpanzee Genome Holds Key to Human Uniqueness



Loading...
The chimpanzee genome, which has existed in draft form since the beginning of this year, is poised to reveal new insights into human health and history, according to Svante Paabo. The renowned molecular anthropologist from the University of Leipzig spoke at a plenary session of the annual meeting of HUGO (the Human Genome Organization), which began in Berlin this week.

Paabo and colleagues bring molecular genetic techniques to bear on questions of human evolution. Few advances in that regard are more important than the imminent completion and publication of the chimpanzee genome sequence.

Chimpanzees are our closest relative in evolution, having diverged about 5 million years ago. The genomes of the two species are 98.8 percent identical at the DNA level – a trivial difference in some respects, although Paabo pointed out that this equates to some 40 million variants in total across the genome, not including numerous rearrangements and insertions and deletions.

A fraction of these variations may hold the key to understanding some of the key evolutionary differences that distinguish humans and chimps – areas such as cognition, language, aging, as well as diseases such as Alzheimer’s, schizophrenia, autism, and susceptibility to infectious diseases (AIDS, malaria), as well as cancer.

As these are likely to be polygenic conditions, however, Paabo cautioned that such insights will only emerge with additional genome resources – including the availability of another non-primate genome, the Rhesus macaque – in conjunction with parallel approaches, including studies of the proteome, transcriptome, and the “phenome.” To improve the phenotypic characterization of non-human primates, Paabo’s institute in Leipzig is building a multidisciplinary team to bolster research in primate physiology and social behavior, fields he says have been sorely neglected in the past. “We need to understand the phenotypic differences between chimps and humans,” says Paabo.

Early Insights
Paabo illustrated two examples of early insights into the biology of humanness that preliminary analysis of the chimp sequence has entailed.

First was the field of smell, which is governed by a family of about 1,000 odorant receptors (ORs) in the nose. These ORs transmit nerve signals to the brain that result in the sense of smell. In humans, however, more than half of these receptors are pseudogenes – genes that have withered via mutation and are no longer functional. This contrasts with mice, which have very few pseudogenes. Chimpanzees lie in the middle, having about 30 percent pseudogenes in the OR family. Thus humans are steadily losing functional OR genes – even to the present day. However, there is also evidence for positive selection in at least a subset of OR genes, suggesting that some OR genes may acquire new functions over time.

A second area highlighted by Paabo is the transcriptome. In studies performed using Affymetrix chips, surveys of different regions of the brain have consistently revealed 5-6 percent differences in gene expression. Overall, about 10 percent of the human/chimp genome shows significant difference of expression in some area of the brain. But are these differences functionally significant? To put it another way, are they the result of Darwinian selection or the neutral theory of evolution?

Paabo listed three predictions that would be expected if the sum changes were neutral, rather than the result of selection. However, studies on expression differences between species do not reject any of these predictions, suggesting that the changes seen for the majority of these genes do not appear to have widespread functional significance.

Two other speakers also discussed the pros of comparative genomics. Jenny Marshall-Graves (Australian National University, Canberra) spoke passionately of the virtues of the kangaroo and its “eight gorgeous chromosomes.” Marsupials diverged from eutherian mammals (including humans and primates) about 180 million years ago, and represent the first steps of mammalian evolution. The kangaroo embryo is born about the size of a pea, and is little more than “a mouth, a gut, and a pair of hands to get up to the mother’s pouch,” providing an exciting model for the study of early development. Graves said that a promising candidate gene for pouch development has been identified on the X chromosome. “Maybe we can give pouches to other animals – even humans!” she quipped.

Evan Eichler (Case Western University) highlighted the significance of segmental duplications in the human genome, either on the same chromosome (intrachromosomal) or between chromosomes (interchromosomal). About 150 million bases – the equivalent of a single chromosome – consist of duplicated regions of DNA. Rearrangement of these regions can increase susceptibility to diseases, including cancer.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Quantum
StorNext 4.0: Technical Product Brief
Sponsored by Quantum

 
Proven in the world’s most data intensive industries, Quantum StorNext is a scalable, high-performance file system which allows data sharing across Linux, Mac, Unix, and Windows operating systems and manages data in enterprise storage environments. In this Technical Brief you'll learn:

  • How a high-performing file system can accelerate your business
  • How to simplify your data management
  • How a tiered storage approach can save you money


SURETY-IP_WPx108
Protect Your Scientific Intellectual Property: Proof of Lab Informatics Data Authenticity is Your Best Legal Defense
Sponsored by Surety, LLC

As a bio-technology or life sciences organization, your formulas, treatments and research and discoveries are the “lifeblood” of your business. But if you aren't protecting the integrity of your scientific data in your lab informatics systems, you risk losing IP ownership, revenue and consequently your business if you can't prove time-of-creation and data authenticity. Learn how you can implement simple, cost-effective and automated controls to protect your scientific intellectual property. Consider:

  • IP protection requirements in bio-pharma and other science-oriented industries can extend out 20, 30, 40 or more years
  • Most electronic lab management solutions include generic authenticity controls, so how "legally defensible" is yours?
  • Only standards-compliant, independent controls can future-proof your approach to long-term IP integrity protection and authenticity.
  • Learn more - get the free whitepaper now


BlueArc_WP_DataMigration.jpg
The Key to Life Sciences Data Management: Transparent Migration
Sponsored by BlueArc

Life sciences organizations face new data management challenges as the volume of research data grows and more data is kept online for longer times. Read this paper to learn about:

  • The benefits of transparent data migration (TDM)
  • How TDM technologies can simplify data management.
  • How using TDM can help increase storage utilization, improve computational workflow performance, and optimize the use of storage resources.


Life Science Webcasts & Podcasts

adobe_i3_btn_webinarNext-Generation Clinical Trial and Data Management Applications
Sponsored by Adobe

This webinar introduces i3Cube - a web-based, fully integrated, clinical trial and data management system built on Adobe’s LiveCycle® Enterprise Suite.  I3 cube provides end-to-end automation that delivers unprecedented visibility into information that sponsors need to accelerate the study process and complete trials efficiently. Viewers will learn more about:

  • Creating faster and more efficient trial processes
  • Reducing investigator burden 
  • Real-time sponsor transparency into study information
  • Enterprise solutions based on Adobe LiveCycle® ES utilizing cross-platform clients of Reader, Flash and AIR

    Download now.



More Podcasts

Job Openings

Employers -- Don't miss this opportunity to reach well-qualified life science candidates.

Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.